VVM
IPSC icon

Versant Venture Management’s Century Therapeutics IPSC Stock Holding History

Versant Venture Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.5M Buy
+12,166,109
New +$25.6M 19.44% 2

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Versant Venture Management's IPSC Position: Q1 2026 in Review

Versant Venture Management opened a new position in Century Therapeutics (IPSC) in Q1 2026: 12,166,109 shares worth $27.5M. The stake represents 19.44% of the portfolio and ranks #2 among its holdings.

72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Versant Venture Management held 12,166,109 shares of Century Therapeutics worth $27.5M as of Q1 2026.
  • Century Therapeutics was a new Versant Venture Management position in Q1 2026.
  • Century Therapeutics made up 19.44% of Versant Venture Management's portfolio in Q1 2026, its #2 holding.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Versant Venture Management's 13F filing for Q1 2026, filed 5 May 2026.